Eva Salinas Selected Research

caseinomacropeptide

11/2020	Protective Effect of Glycomacropeptide on the Atopic Dermatitis-Like Dysfunctional Skin Barrier in Rats.
9/2020	Protective Effect of Glycomacropeptide on Food Allergy with Gastrointestinal Manifestations in a Rat Model through Down-Regulation of Type 2 Immune Response.
5/2020	Glycomacropeptide Ameliorates Indomethacin-Induced Enteropathy in Rats by Modifying Intestinal Inflammation and Oxidative Stress.
1/2017	Glycomacropeptide Attenuates Inflammation, Pruritus, and Th2 Response Associated with Atopic Dermatitis Induced by 2,4-Dinitrochlorobenzene in Rat.
4/2016	Glycomacropeptide administration attenuates airway inflammation and remodeling associated to allergic asthma in rat.
1/2016	Novel Mechanisms Underlying the Therapeutic Effect of Glycomacropeptide on Allergy: Change in Gut Microbiota, Upregulation of TGF-β, and Inhibition of Mast Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva Salinas Research Topics

Disease

7	Inflammation (Inflammations) 07/2021 - 01/2008
4	Hyperplasia 01/2021 - 04/2016
3	Atopic Dermatitis (Atopic Eczema) 10/2021 - 01/2017
3	Infections 10/2021 - 01/2017
3	Anaphylaxis (Anaphylactic Shock) 09/2020 - 12/2009
3	Hypersensitivity (Allergy) 01/2020 - 12/2009
3	Asthma (Bronchial Asthma) 01/2019 - 01/2016
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016 - 02/2011
3	Multiple Sclerosis 01/2016 - 02/2011
2	Neoplasms (Cancer) 01/2021 - 01/2018
2	Dermatitis 11/2020 - 01/2017
2	Edema (Dropsy) 09/2020 - 01/2017
2	Food Hypersensitivity (Food Allergy) 09/2020 - 01/2020
1	Uterine Cervical Dysplasia 01/2021
1	Diarrhea 09/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Human Influenza (Influenza) 01/2019
1	Tuberculosis (Tuberculoses) 01/2018
1	Latent Tuberculosis 01/2018
1	Fibrosis (Cirrhosis) 12/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2017
1	Pruritus (Itching) 01/2017
1	Eosinophilia 04/2016
1	Spinal Cord Compression 11/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2015
1	Mycoses (Diseases, Fungus) 11/2014
1	Leiomyoma (Uterine Fibroids) 10/2012
1	Prostatic Neoplasms (Prostate Cancer) 10/2012
1	Precocious Puberty 10/2012
1	Endometriosis 10/2012
1	Body Weight (Weight, Body) 10/2012
1	Sepsis (Septicemia) 12/2009
1	Neurocysticercosis 07/2003

Drug/Important Bio-Agent (IBA)

6	caseinomacropeptideIBA 11/2020 - 01/2016
5	AllergensIBA 07/2021 - 12/2009
5	Immunoglobulin E (IgE)IBA 09/2020 - 12/2009
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2016 - 02/2011
3	Leuprolide (Lupron)FDA LinkGeneric 01/2016 - 10/2012
2	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 12/2017
2	CollagenIBA 01/2021 - 04/2016
2	Dinitrochlorobenzene (DNCB)IBA 11/2020 - 01/2017
2	CytokinesIBA 09/2020 - 01/2017
2	Histamine (Histamine Dihydrochloride)FDA Link 09/2020 - 12/2009
2	Anti-Infective Agents (Microbicides)IBA 01/2020 - 01/2017
2	Peptides (Polypeptides)IBA 01/2018 - 01/2016
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2021
1	Phenobarbital (Luminal)FDA Link 07/2021
1	ProteomeIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 05/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	AntigensIBA 01/2020
1	MicronutrientsIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Nucleosomes (Nucleosome)IBA 01/2018
1	EnzymesIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2017
1	Doxazosin (Cardura)FDA LinkGeneric 12/2017
1	Therapeutic UsesIBA 01/2016
1	PrebioticsIBA 01/2016
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2016
1	Saline SolutionIBA 11/2015
1	Interleukin-6 (Interleukin 6)IBA 11/2014
1	Myelin Basic ProteinIBA 10/2012
1	Pharmaceutical PreparationsIBA 10/2012
1	QuercetinIBA 01/2008
1	FlavonoidsIBA 01/2008
1	Glial Fibrillary Acidic ProteinIBA 07/2003

Therapy/Procedure

5	Therapeutics 10/2021 - 10/2012
2	Oral Administration 01/2021 - 01/2008